Welcome to our dedicated page for McKesson news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson stock.
McKesson Corporation (symbol: MCK) is a leading healthcare services and information technology company, dedicated to improving the business of healthcare globally. Ranked 11th on the Fortune 500 list, McKesson collaborates with a diverse range of stakeholders including payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and other entities across the healthcare spectrum. The company's mission is to foster healthier organizations that deliver superior care to patients in every setting.
McKesson is one of the top three pharmaceutical wholesalers in the United States, engaging in the sourcing and distribution of branded, generic, and specialty pharmaceutical products. Their extensive client base includes retail chains, independent pharmacies, mail-order pharmacies, hospital networks, and healthcare providers. Alongside Cencora and Cardinal Health, McKesson commands over 90% of the US pharmaceutical wholesale industry.
Beyond the US, McKesson's reach extends to Canada, where they are involved in pharmaceutical wholesale and distribution. Additionally, McKesson supplies medical-surgical products and equipment to healthcare facilities and offers a range of technology solutions tailored for pharmacies.
McKesson's comprehensive service offerings include pharmaceutical and medical-surgical supply management, healthcare information technology solutions, and business and clinical services. The company is committed to helping its customers enhance their financial, operational, and clinical performance, ultimately aiming to deliver better patient care.
Recent achievements include strategic partnerships and innovative projects that continue to position McKesson as a key player in the healthcare industry. Their ongoing projects are designed to streamline operations and improve efficiency across the board, ensuring that healthcare providers can focus on patient care.
For more details on McKesson Corporation, visit www.mckesson.com.
The Board of Directors of McKesson Corporation (NYSE:MCK) declared a regular dividend of 54 cents per share. This dividend is set to be paid on January 3, 2023, to stockholders of record as of December 1, 2022. McKesson, a leader in healthcare services, aims to improve health outcomes by collaborating with various stakeholders in the healthcare ecosystem.
McKesson Corporation (NYSE: MCK) announced an extension of its partnership with CVS Health to distribute pharmaceuticals through June 2027. This partnership, which has lasted over 20 years, aims to improve health outcomes for patients. Additionally, McKesson will release its second-quarter fiscal 2023 earnings results on November 1, 2022, with a conference call scheduled at 4:30 PM Eastern Time. The live webcast will be accessible through McKesson's Investor Relations website.
McKesson Corporation (NYSE:MCK) has announced the acquisition of Rx Savings Solutions for up to
McKesson Corporation (NYSE:MCK) has announced the appointment of LeAnn B. Smith as the new executive vice president and chief human resources officer (CHRO), effective December 1, 2022. She will succeed Tracy L. Faber, who is retiring after 11 years. Smith, who joined McKesson in 2021, will oversee all human resources functions, focusing on talent management, diversity, and organizational change. CEO Brian Tyler expressed confidence in Smith's capabilities, highlighting her extensive experience, including a previous role at Walmart.
McKesson Corporation (NYSE: MCK) announced its fiscal 2023 first-quarter financial results, now available on its Investor Relations website. The company will host a live webcast today, August 3, at 4:30 PM ET to discuss these results. McKesson continues to lead in healthcare services, collaborating with various sectors to enhance care accessibility and affordability. The press release indicates a commitment to delivering insights and services that improve health outcomes across the healthcare spectrum.
On July 22, 2022, McKesson Corporation (NYSE:MCK) declared a regular dividend of $0.54 per share, marking a 15% increase from the previous $0.47. The dividend will be payable on October 3, 2022, to shareholders of record as of September 1, 2022. CEO Brian Tyler emphasized the dividend increase reflects robust cash flow and the company’s confidence in its long-term growth strategy. Notably, this marks the sixth consecutive year of dividend increases for McKesson.
McKesson Corporation (NYSE: MCK) will announce its first quarter fiscal 2023 financial results on August 3, 2022, after market close. The company will conduct a live webcast at 4:30 PM Eastern Time to discuss the results. Investors can access the webcast and related financial documentation on the company’s Investor Relations website. McKesson is committed to improving health outcomes and providing affordable healthcare solutions through partnerships with various stakeholders in the healthcare sector.
McKesson Corporation and HCA Healthcare have announced a joint venture to combine their oncology research arms, US Oncology Research and Sarah Cannon Research Institute, enhancing clinical trial access and drug development. This venture aims to expand oncology research, streamline trial matching for patients, and improve access, particularly for underserved communities. McKesson will hold 51% ownership, with the joint venture expected to close in 2022. Financial details remain undisclosed, and the agreement is subject to regulatory approvals.
McKesson Corporation and HCA Healthcare have announced a joint venture to combine their oncology research efforts, enhancing clinical trials and treatment options for cancer patients. The venture will merge McKesson’s US Oncology Research with HCA’s Sarah Cannon Research Institute, aiming to improve access and accelerate cancer drug development, especially in underserved communities. McKesson will hold a 51% stake and operating control. The deal is expected to close in 2022, pending regulatory approval and customary conditions.
McKesson Corporation (NYSE: MCK) announced its fiscal 2022 fourth-quarter financial results, which are accessible through its Investor Relations website. A live webcast of the earnings conference call is scheduled for May 5 at 4:30 PM ET, allowing investors to review the results in detail. McKesson aims to enhance healthcare accessibility and affordability through partnerships with various healthcare entities. More information is available on their official website.
FAQ
What is the current stock price of McKesson (MCK)?
What is the market cap of McKesson (MCK)?
What services does McKesson Corporation provide?
Where does McKesson Corporation operate?
Who are McKesson's primary clients?
What makes McKesson a leading pharmaceutical wholesaler?
How does McKesson help improve healthcare delivery?
What are some recent achievements of McKesson Corporation?
Can individuals buy products directly from McKesson?
How does McKesson contribute to the healthcare industry?
What is the significance of McKesson's partnerships?
Where can I find more information about McKesson Corporation?
